FDA Inspection 662221 — Hospira, Inc.
The FDA completed an inspection of Hospira, Inc. on May 18, 2010 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 18, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Lake Forest, IL (United States)